$1 USD Pharma Stocks

Investing in US equities is key to diversifying your asset portfolio. In the midst of the COVID-19 pandemic many investors have shown increased interest in pharmaceutical shares. There are three pharma companies whose share prices are less than or a little over one(1) United States Dollar (USD). They are Agile Therapeutics, Neoleukin Therapeutics and Leap Therapeutics which are all listed on the NASDAQ. These companies have some of the cheapest stock prices for pharmaceutical companies in the United States. Based on your investment strategy, and after doing thorough research, one of these cheap stocks may be where you can start your journey of buying shares in pharmaceutical companies. Most individual investors cannot afford expensive shares such as that of Berkshire Hathaway and opt for cheaper shares or fractional shares. Online trading platforms now give everyday stock market investors the option of owning fractional shares which became more popular since the COVID-19 pandemic. This is levelling the playing field so that everyone can get a chance of being part of investing on stock exchanges regardless of how much money they have. For as low as $1 USD, you can own shares in a pharma company.

Cheap stocks are not always the best to own, however, it is a place to start as a learning tool for the everyday investor. If not, you can opt for fractional shares which would allow you to own 0.01% of a BRK-A share for $4218 USD. Medical Laboratories will become some of the largest publicly-listed companies in the future when DNA starts to replace software as the most popular product on planet Earth.

Disclaimer: This information should not be taken as investment advice. Please contact your licensed investment advisor before making any investment decision. 

Investing in Pharmaceuticals

Investing is very risky. Hence, it is important to do thorough research of the companies that you are investing in. The share price of Berkshire Hathaway is currently the most expensive in the world due to the fact that this holding company is the brainchild of Warren Buffett who is the godfather of modern day investing. After looking at the assets owned by Berkshire Hathaway, it is evident that since the COVID-19 pandemic they have invested more in pharmaceuticals. Pharmaceutical companies such as Pfizer, Merck, Teva, Bristol-Myers-Squibb, and Abbvie Inc. are some examples of assets that are owned by Berkshire Hathaway.

It is without a doubt that a healthcare boom is coming as predicted by Michael Lee-Chin in a strategic initiative letter in 2021. More investors such as Warren Buffett are starting to research pharmaceutical companies to see which one will be the best to invest in. That pharmaceutical company will probably have the next great medical breakthrough in genetics. Medical Laboratories will be some of the largest publicly-listed companies in the future since DNA will replace software as the most popular product on planet Earth. On the Jamaica Stock Exchange there are pharmaceutical companies such as Fontana, Medical Disposables and Indies Pharma that you can invest in. 

Disclaimer: This information should not be taken as investment advice. Please contact your licensed investment advisor before making any investment decision.

Medical Microinsurance

The exorbitant cost of healthcare has caused many to avoid the healthcare system completely because of affordability issues. Many persons are still unbanked and uninsured which results in those persons unable to access a medical loan or health insurance. This is a major drawback in the development of an effective healthcare system. Medical Laboratories charge exorbitant fees for blood tests that are not subsidized by the government or health insurance. This makes access to diagnostics and pharmaceuticals a luxury for a few. A solution to this is the access to medical microinsurance for the unbanked and uninsured. This can be simply in the form of a medical cost sharing program. These programs are sometimes called healthcare ministries in many christian organizations.

According to Michael Lee-Chin, chairman of Portland Holdings, a healthcare boom is on the verge of happening. The data suggests that investments in healthcare companies will provide high returns in the future. Medical Laboratories play a major role in this healthcare boom that Michael Lee-Chin is predicting.

Becoming an Inventor

Becoming an inventor does not require you to be super brilliant. Inventions are created using a three step formula. These steps include: Initiation, Imitation and Innovation. A simple and mathematical way to remember this formula is Invention = Initiation + Imitation + Innovation. The first step which is Initiation is to study the field that you want create an invention in. For example if you want to invent a diagnostic test then you have to study medical laboratory science and engineering. This means reading academic papers, research literature and books about the subject. This will help you with initiating your mind to think about how your invention will add value to society. The second step which is Imitation is to filter through all of the literature and find strategies that you can copy. After copying these strategies then you need to practice them daily until you are perfect. Through practicing you will automatically start to find new strategies that no one has ever tried before. Finding new and unique strategies through experimentation is what leads you to the Innovation step. 

This is how anyone can become an inventor. First you need to start studying the subject, then find strategies to copy, then experiment with new and unique strategies. Medical Laboratories allow engineers to invent devices for genetic engineering of humans. The same three step formula is what those engineers are using to create the final invention of the human race. Simple engineering of the human body (i.e. bodybuilding) can be done with exercise, diet and monitoring of chemicals in the blood and urine. Bioengineering of humans is as easy as losing weight with exercise and as complex as editing human genes with CRISPR. 

Datasets in Molecular Biology

Finding the needle in the haystack is what health data analytics is all about. Factors that can affect the needle found include poor data quality, poor data governance and poor data preparation. The use of data to create expert systems that operate similar or superior to physicians is the final innovation for healthcare. This innovation will intertwine the subject areas of artificial intelligence and genetic engineering. A dataset in molecular biology could predict whether a patient will have cancer in the future. There are several research and development initiatives aimed at creating what I call "ROBO-DOCTOR" which is an expert system for healthcare. This will incorporate the use of therapeutic and diagnostic data as well as a decision support system that can predict future health outcomes. 

The Medical Laboratory will be at the center of this innovation in health analytics/ healthcare informatics. This is due to fact that 70% of the data used for diagnosing patients are obtained from the Medical Laboratory.

Product Sourcing Strategy for DNA

DNA is the software of life. The product sourcing strategies for software include in-house software development, commercial-off-the-shelf packages, cloud computing, mobile computing or open source software. These product sourcing strategies can also be applied to DNA. Genetic engineering provides the expertise and framework for in-house engineering of synthetic DNA. Commercial options are also available for synthetic DNA that is sold off the shelf such as from Twist Biosciences. Open source, cloud computing, and mobile computing are available in the form of BLAST (basic local alignment search tool) which is the Google of biological data. This is a search engine and database which has an algorithm that compares primary biological sequence information.

Medical Laboratories are at the heart of sourcing DNA solutions. Everyone should become part of the DNA software revolution. 

Open Source Educational LIMS

G-MOSS (Gav-Med Open Source Society) is the ultimate free and open-source healthcare group for open source laboratory information management systems. Its focus is on data and life as subject areas that everyone can learn for free online via open-source education. Data is viewed from the perspective of artificial intelligence and Life is viewed from the perspective of genetic engineering. We believe that path to a self-taught education is via the internet and is possible with the symbiosis of artificial and biological intelligence. Linus's law states that 'given enough eyeballs, all bugs are shallow'. This means that everyone should learn and participate in the development of artificial intelligence and genetic engineering. 

Medical Laboratories are playing an important role in the development of open-source technologies used in healthcare for understanding data and life. A free and accredited bachelors degree in computer science will soon be realized via the internet. Free and open-source online learning will revolutionize the information age thus leading to the symbiosis of artificial intelligence and genetic engineering which will create superhumans.